|
Federal
Register Notices > Manufacturers 2008
>
Aldrich Chemical Company Inc., DBA Isotec
FR Doc E8-8176[Federal Register: April 16, 2008 (Volume 73, Number 74)]
[Notices] [Page 20718-20719] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16ap08-108]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on March 18, 2008, Aldrich Chemical Company Inc., DBA Isotec, 3858
Benner Road, Miamisburg, Ohio 45342-4304, made application by renewal to the
Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
Aminorex (1585)
|
I
|
|
Gamma Hydroxybutyric Acid (2010)
|
I
|
|
Methaqualone (2565)
|
I
|
|
Ibogaine (7260)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
N-Ethyl-1-phenylcyclohexylamine (7455)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Normorphine (9313)
|
I
|
|
Acetylmethadol (9601)
|
I
|
|
Alphacetylmethadol except levo-alphacetylmethadol (9603)
|
I
|
|
Normethadone (9635)
|
I
|
|
Norpipanone (9636)
|
I
|
|
3-Methylfentanyl (9813)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
1-Piperidinocyclohexanecarbonitrile (8603)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Isomethadone (9226)
|
II
|
|
Meperidine (9230)
|
II
|
|
Meperidine Intermediate--A (9232)
|
II
|
|
Meperidine Intermediate--B (9233)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone Intermediate (9254)
|
II
|
|
Dextropropoxyphene, bulk, (non-dosage forms) (9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances to produce isotope labeled standards for drug testing and analysis.
Any other such applicant, and any person who is presently registered with DEA
to manufacture such substances, may file comments or objections to the issuance
of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, DC 20537,
or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later
than June 16, 2008.
Dated: April 9, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-8176 Filed 4-15-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
